These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35958818)

  • 1. Antineoplastic Effects of Ankaferd Hemostat.
    Malkan UY; Haznedaroglu IC
    Biomed Res Int; 2022; 2022():2665903. PubMed ID: 35958818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
    Beyazit F; Beyazit Y; Tanoglu A; Haznedaroglu IC
    Med Hypotheses; 2020 Oct; 143():110150. PubMed ID: 32763660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankaferd hemostat: from molecules to medicine.
    Çiftçiler R; Haznedaroglu İC
    Turk J Med Sci; 2020 Nov; 50(SI-2):1739-1750. PubMed ID: 32283900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach.
    Koçak E; Çelebier M; Haznedaroglu IC; Altınöz S
    Biomed Res Int; 2019; 2019():5268031. PubMed ID: 31240215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and preventative effects of ankaferd blood stopper in an experimental necrotizing enterocolitis model.
    Buyuktiryaki M; Tayman C; Koyuncu I; Cakir U; Taskin Turkmenoglu T; Cakir E; Okur N
    Biomed Pharmacother; 2019 Feb; 110():105-110. PubMed ID: 30465999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
    Ciftciler R; Ciftciler AE; Malkan UY; Haznedaroglu IC
    SAGE Open Med; 2020; 8():2050312120907811. PubMed ID: 32110403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy.
    Karacan Y; Yıldız H; Evrensel T; Haznedaroglu IC
    Support Care Cancer; 2023 Jun; 31(7):385. PubMed ID: 37289263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A candidate antineoplastic herbal agent for bladder cancer: Ankaferd Blood Stopper.
    Sarı H; Çelik S; Çağlar F; Aktaş S; Bozkurt O; Yörükoğlu K; Çelebi İ; Mungan MU
    Int J Clin Pract; 2021 Nov; 75(11):e14789. PubMed ID: 34480836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine.
    Okay M; Ozturk Y; Haznedaroglu IC
    Clin Appl Thromb Hemost; 2019; 25():1076029618824416. PubMed ID: 30808215
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Ankaferd on anastomotic healing of colon.
    Cancan G; Teksoz S; Aytac E; Arikan AE; Erman H; Uzun H; Ozden F; Aydin O; Ozcan M
    J Invest Surg; 2014 Feb; 27(1):1-6. PubMed ID: 23987308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankaferd hemostat in the management of gastrointestinal hemorrhages.
    Beyazit Y; Kekilli M; Haznedaroglu IC; Kayacetin E; Basaranoglu M
    World J Gastroenterol; 2011 Sep; 17(35):3962-70. PubMed ID: 22046083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat.
    Haznedaroglu BZ; Beyazit Y; Walker SL; Haznedaroglu IC
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):21-34. PubMed ID: 22079213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study.
    Çiftçiler R; Aksu S; Dikmenoğlu Falkmarken N; Haznedaroğlu İC
    Turk J Med Sci; 2019 Feb; 49(1):356-360. PubMed ID: 30761848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat.
    Haznedaroğlu IC; Çelebier M
    Turk J Med Sci; 2020 Aug; 50(5):1434-1435. PubMed ID: 32305048
    [No Abstract]   [Full Text] [Related]  

  • 15. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures.
    Kurt M; Onal I; Akdogan M; Kekilli M; Arhan M; Sayilir A; Oztas E; Haznedaroglu I
    Can J Gastroenterol; 2010 Jun; 24(6):380-4. PubMed ID: 20559581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat.
    Uzun O; Erkan L; Haznedaroglu IC
    Arch Bronconeumol; 2014 Sep; 50(9):407-9. PubMed ID: 24491888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.
    Huri E; Beyazit Y; Mammadov R; Toksoz S; Tekinay AB; Guler MO; Ustun H; Kekilli M; Dadali M; Celik T; Astarci M; Haznedaroglu IC
    Int J Biomater; 2013; 2013():949460. PubMed ID: 23509463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing.
    Işler SC; Demircan S; Cakarer S; Cebi Z; Keskin C; Soluk M; Yüzbaşioğlu E
    J Appl Oral Sci; 2010; 18(4):409-14. PubMed ID: 20835578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study.
    Bulut E; Baş B; Altunkaynak BZ; Bekçioğlu B; Erdem Koç G; Gönülol E; Önger ME; Kaplan S
    Biotech Histochem; 2014 Oct; 89(7):535-43. PubMed ID: 24799094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial.
    Beyazit Y; Kart T; Kuscu A; Arslan A; Kurt M; Aktas B; Kekilli M; Haznedaroglu I
    J Contemp Dent Pract; 2011 Sep; 12(5):379-84. PubMed ID: 22269200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.